文献速递系统性红斑狼疮血管炎

关联研究鉴定HLA-DQA1为系统性红斑狼疮相关肺动脉高压的新型遗传风险因素

Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
PubMed 文献 · Arthritis Rheumatol · 2023-10-24

研究纳入172例经右心导管确诊的SLE相关PAH患者、1303例无PAH的SLE患者和9906例健康对照,对MHC区域深度测序,发现HLA-DQA1*03:02与SLE相关PAH相关(发现队列P=5.68×10⁻¹²,复制队列P=1.30×10⁻⁹),且该等位基因携带者靶目标达成率(P=0.005)和生存率(P=0.04)显著更低。

要点

  • HLA-DQA1*03:02是SLE相关PAH的新型遗传风险因素,在发现和复制队列中均获验证。
  • 携带HLA-DQA1*03:02的SLE相关PAH患者靶目标达成率和生存率显著更低。
  • 作者认为携带该等位基因的SLE患者需定期监测和仔细随访,以早期诊断和干预潜在PAH。

核心结论

  • HLA-DQA1*03:02是SLE相关PAH的新型遗传风险因素和预后因素。
  • 作者认为携带该等位基因的SLE患者需要定期监测和仔细随访,以便对潜在PAH进行早期诊断和干预。

研究设计与样本

  • 纳入172例经右心导管确诊的SLE相关PAH患者、1303例无PAH的SLE患者和9906例健康对照。
  • 对MHC区域进行深度测序以鉴定等位基因、单核苷酸多态性和氨基酸,并将SLE相关PAH患者与无PAH的SLE患者及健康对照进行比较。
  • 开展临床关联研究以探索其对表型的贡献。

主要发现

  • 在MHC区域内共鉴定出19881个遗传变异。
  • HLA-DQA1*03:02在发现队列中与SLE相关PAH相关(P=5.68×10⁻¹²),并在独立复制队列中得到验证(P=1.30×10⁻⁹)。
  • 最强关联的氨基酸位置定位于HLA-DQα1,该区域影响MHC/肽-CD4+ T细胞受体亲和力和抗原结合。
  • 携带HLA-DQA1*03:02的SLE相关PAH患者靶目标达成率显著更低(P=0.005),生存率显著更低(P=0.04)。

临床怎么用

  • 作者认为携带HLA-DQA1*03:02的SLE患者需要定期监测和仔细随访,以便对潜在PAH进行早期诊断和干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pulmonary arterial hypertension (PAH) is a severe complication of systemic lupus erythematosus (SLE). However, the genetic signatures of SLE-associated PAH have not been well studied. We aimed to identify genetic variants implicated in SLE-associated PAH susceptibility within the major histocompatibility complex (MHC) region and assess the contribution to clinical outcomes. METHODS: A total of 172 patients with SLE-associated PAH confirmed by right heart catheterization, 1,303 patients with SLE without PAH, and 9,906 healthy controls were included. Deep sequencing of the MHC region was performed to identify alleles, single-nucleotide polymorphisms, and amino acids. We compared patients with SLE-associated PAH with patients with SLE without PAH and healthy controls. Clinical association study was conducted to explore the contribution to phenotypes. RESULTS: A total of 19,881 genetic variants were identified within the MHC region. HLA-DQA1*03:02 was identified as a novel genetic variant associated with SLE-associated PAH in the discovery cohort (P = 5.68 × 10-12 ) and authenticated in an independent replication cohort (P = 1.30 × 10-9 ). The strongest associated amino acid position was mapped to HLA-DQα1 in the region affecting MHC/peptide-CD4+ T cell receptor affinity and antigen binding. Clinical association study demonstrated that patients with SLE-associated PAH with HLA-DQA1*03:02 had significantly lower rates of target role achievement (P = 0.005) and survival (P = 0.04). CONCLUSION: This study, based on the largest cohort of SLE-associated PAH, is the first to investigate how MHC region genetic variants contribute to SLE-associated PAH susceptibility. HLA-DQA1*03:02 is a novel genetic risk factor and a prognostic factor in SLE-associated PAH. Patients with SLE with this allele require regular monitoring and careful follow-up for early diagnosis and interventions for potential PAH.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Qian J, Chen Y, Yang X, et al. Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Arthritis Rheumatol. 2023. PMID: 37382296. doi:10.1002/art.42641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。